Atara Biotherapeutics, Inc. (ATRA) stock
ATRANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 3/30
$6.77+0.27 (+4.15%)
Close on Nov 18, 2026Market cap $67.96MP/E –Yield –
Atara Biotherapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Atara Biotherapeutics's market cap was $77.72M on Nov 11, 2026, against $108.87M a year earlier. Over the last 5 years it ranged from $34.64M to $1.39B, with a median of $84.08M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $77.72M | -40.4% |
| 2025 | Dec 31, 2025 | $130.43M | +70.7% |
| 2024 | Dec 31, 2024 | $76.40M | +46.2% |
| 2023 | Dec 29, 2023 | $52.27M | -83.2% |
| 2022 | Dec 30, 2022 | $311.20M | -77.7% |
| 2021 | Dec 31, 2021 | $1.39B | -8.1% |
| 2020 | Dec 31, 2020 | $1.52B | +70.0% |
| 2019 | Dec 31, 2019 | $891.44M | -43.8% |
| 2018 | Dec 31, 2018 | $1.59B | +286201.1% |
| 2017 | Dec 29, 2017 | $553.86K | -99.9% |
| 2016 | Dec 30, 2016 | $409.56M | -45.3% |
| 2015 | Dec 31, 2015 | $748.09M | +1752.4% |
| 2014 | Dec 31, 2014 | $40.38M | – |
See a number that looks wrong?